Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression, Nat Med, 2000. ,
Isolation and characterization of human antigen-specific TCR alpha beta+ CD4(-)CD8-double-negative regulatory T cells, Blood, vol.105, issue.7, pp.2828-2835, 2005. ,
, Club rhumatismes et inflammations, fiches immunoloqie, 20072.
Lymphocytes T non conventionnels circulants détectés par cytométrie en flux. Immunologie, 2005. ,
Intraepithelial ?? T lymphocytes: sentinel cells at mucosal barriers, Springer Seminars in Immunopathology, vol.22, pp.283-296, 2000. ,
Antitumor activity of expanded human tumor-infiltrating gammadelta T lymphocytes, Int Arch Allergy Immunol, vol.125, issue.3, pp.256-263, 2001. ,
Adaptive immune response of Vgamma2Vdelta2 T cells: a new paradigm, Trends Immunol, vol.24, issue.4, pp.213-219, 2003. ,
Vdelta1 and Vdelta2 gammadelta T cells express distinct surface markers and might be developmentally distinct lineages, J Leukoc Biol, vol.70, issue.4, pp.518-526, 2001. ,
, Vdelta1 and Vdelta2 gammadelta T cells express distinct surface markers and might be developmentally distinct lineages. De Rosa, J Leukoc Biol, 2001.
A keratinocyte-responsive gamma delta TCR is necessary for dendritic epidermal T cell activation by damaged keratinocytes and maintenance in the epidermis, J Immunol, vol.172, issue.6, pp.3573-3579, 2004. ,
, Collège des Enseignants d'Immunologie. Immunologie fondamentale et immunopathologie, pp.2-3
2 ème édition, 2018. ,
The thymus in allogeneic haematopoietic stem cell transplantation, vol.18, 2012. ,
Anomalies d'expression du complexe récepteur T de l'antigène/CD3 et déficits immunitaires, Med Sci, vol.23, issue.2, pp.161-166, 2007. ,
, , 2011.
Why must T cells be cross-reactive?, Nat Rev Immunol, vol.12, issue.9, pp.669-677, 2012. ,
TCR??+CD3+CD4-CD8-(double negative) T cells in autoimmunity, Autoimmun Rev, vol.17, issue.4, pp.422-430, 2018. ,
Molecular mechanisms for the assembly of the T cell receptor-CD3 complex, Mol Immunol, vol.40, issue.18, pp.1295-1305, 2004. ,
The T-cell receptor signalosome: a dynamic structure with expanding complexity, 18 CD3 complex and immunodeficiencies Le Deist Med Sci, vol.14, pp.299-305, 2002. ,
Anomalies d'expression du complexe récepteur T de l'antigène/CD3 et déficits immunitaires, Med Sci, vol.23, issue.2, pp.161-166, 2007. ,
Double negative (DN) ?? T cells: misperception and overdue recognition, Immunol Cell Biol, vol.93, issue.3, pp.305-310, 2015. ,
Human alpha beta and gamma delta thymocyte development: TCR gene rearrangements, intracellular TCR beta expression, and gamma delta developmental potential--differences between men and mice, J Immunol, vol.176, issue.3, pp.1543-1552, 2006. ,
The production of alpha/beta and gamma/delta double negative (DN) Tcells and their role in the maintenance of pregnancy, Reprod Biol Endocrinol, vol.13, p.73, 2015. ,
New insights on human T cell development by quantitative T cell receptor gene rearrangement studies and gene expression profiling, J Exp Med, vol.201, pp.1715-1738, 2005. ,
Development of alphabeta T cells in the human thymus, Nat Rev Immunol, vol.2, pp.760-72, 2002. ,
Negative selection, not receptor editing, is a physiological response of autoreactive thymocytes, J Exp Med, vol.210, issue.10, pp.1911-1918, 2013. ,
Human ?? and ?? thymocyte development: TCR gene rearrangements, intracellular TCR? expression and ?? developmental potential -differences between men and mice, J Immunol Baltim Md, vol.176, pp.1543-52, 1950. ,
TCR signal strength influences alphabeta/gammadelta lineage fate, Immunity, vol.22, pp.583-93, 2005. ,
??T cell receptors expressed by CD4?CD8??? intraepithelial T cells drive their fate into a unique lineagewith unusualMHC reactivities, Immunity, vol.41, pp.207-225, 2014. ,
Interactions between double positive thymocytes and high affinity ligands presented by cortical epithelial cells generate double negative thymocytes with T cell regulatory activity, Proc Natl Acad Sci, vol.99, issue.4, pp.2181-2186, 2002. ,
The timing of TCR alpha expression critically influences T cell development and selection, J Exp Med, vol.202, issue.1, pp.111-121, 2005. ,
TCR/self-antigen interactions drive double-negative T cell peripheral expansion and differentiation into suppressor cells, J Immunol Baltim Md, vol.167, pp.6188-94, 1950. ,
T cell development in mice that lack the zeta chain of the T cell antigen receptor complex, Advancement of Science, vol.261, issue.5123, pp.918-921, 1993. ,
Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys, J Immunol, vol.181, issue.12, pp.8761-8766, 2008. ,
Elevated double negative T cells in pediatric autoimmunity, J Clin Immunol, vol.34, issue.5, pp.594-599, 2014. ,
Epigenetic regulation of cytokine expression in systemic lupus erythematosus with special focus on T cells, Autoimmunity, vol.47, issue.4, pp.234-241, 2014. ,
Transcriptional enhancers in the regulation of T cell differentiation, Front. Immunol, 2015. ,
Appropriate developmental expression of human CD8 beta in transgenic mice, J Immunol, vol.159, issue.10, pp.4907-4912, 1997. ,
CD8 expression up to the double-positive CD3(low/intermediate) stage of thymic differentiation is sufficient for development of peripheral functional cytotoxic T lymphocytes, J Exp Med, 2001. ,
Thymic differentiation of TCR alpha beta(+) CD8 alpha alpha(+) IELs, Immunol Rev, vol.215, pp.178-188, 2007. ,
Negative regulation of CD8 expression via Cd8 enhancer-mediated recruitment of the zinc finger protein MAZR, Nat Immunol, vol.7, issue.4, pp.392-400, 2006. ,
Transcriptional control of CD4 and CD8 coreceptor expression during T cell development, Cell Mol Life Sci, vol.70, issue.23, pp.4537-4553, 2013. ,
Clonal deletion and the fate of autoreactive thymocytes that survive negative selection, Nat Immunol, vol.13, issue.6, pp.569-578, 2012. ,
??T cell receptors expressed by CD4(-)CD8??(-) intraepithelial T cells drive their fate into a unique lineage with unusual MHC reactivities, Immunity, vol.41, issue.2, pp.207-218, 2014. ,
TCR??+CD3+CD4-CD8-(double negative) T cells in autoimmunity, Autoimmun Rev, vol.17, issue.4, pp.422-430, 2018. ,
Double-negative T regulatory cells can develop outside the thymus and do not mature from CD8+ T cell precursors, J Immunol Baltim Md, 2006. ,
New differentiation pathway for double-negative regulatory T cells that regulates the magnitude of immune responses, Blood, vol.109, issue.9, pp.4071-4079, 2007. ,
Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression, Nat Med, vol.6, issue.7, pp.782-789, 2000. ,
The immune regulatory function of lymphoproliferative double negative T cells in vitro and in vivo, J Exp Med, vol.196, issue.2, pp.261-267, 2002. ,
Adoptive transfer of double negative T regulatory cells induces Bcell death in vivo and alters rejection pattern of rat-to-mouse heart transplantation, Xenotransplantation, vol.15, issue.1, pp.56-63, 2008. ,
Donor double-negative Treg promote allogeneic mixed chimerism and tolerance ,
, He KM European journal of immunology, European Journal of Immunology, vol.37, p.12, 2007.
Regulation of antigen-expressing dendritic cells by double negative regulatory T cells ,
, European journal of immunology, vol.41, issue.9, 2011.
Helper T cells down-regulate CD4 expression upon chronic stimulation giving rise to double-negative T cells, Cell Immunol, vol.284, issue.1-2, pp.68-74, 2013. ,
Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression. Nature medicine, 2000. ,
New differentiation pathway for double-negative regulatory T cells that regulates the magnitude of immune responses, Blood, vol.109, issue.9, pp.4071-4079, 2007. ,
Isolation and characterization of human antigen-specific TCR alpha beta+ CD4(-)CD8-double-negative regulatory T cells, Blood, vol.105, issue.7, pp.2828-2835, 2005. ,
Advances on Non-CD4 + Foxp3+ T Regulatory Cells: CD8+, Type 1, and Double Negative T Regulatory Cells in Organ Transplantation, Transplantation, vol.99, issue.8, pp.1553-1559, 2015. ,
Cloned natural suppressor cell lines express the CD3+CD4-CD8-surface phenotype and the alpha, beta heterodimer of the T cell antigen receptor, J Immunol, vol.143, issue.4, pp.1118-1122, 1989. ,
CAMP-responsive element modulator ? (CREM?) trans-represses the transmembrane glycoprotein CD8 and contributes to the generation of CD3+CD4?CD8? T cells in health and disease ,
, J Biol Chem, 2013.
cAMP-responsive element modulator ? (CREM?) trans-represses the transmembrane glycoprotein CD8 and contributes to the generation of CD3+CD4-CD8-T cells in health and disease, J Biol Chem, vol.288, issue.44, pp.31880-31887, 2013. ,
Cd8 enhancer E8I and Runx factors regulate CD8? expression in activated CD8+ T cells, Proc Natl Acad Sci, vol.108, issue.45, pp.18330-18335, 2011. ,
CD3+CD4-CD8-alphabeta-TCR+ T cell as immune regulatory cell, J Mol Med (Berl) ,
Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression, Nat Med, vol.6, issue.7, pp.782-789, 2000. ,
CD3+CD4-CD8-alphabeta-TCR+ T cell as immune regulatory cell, J Mol Med (Berl) ,
Double negative regulatory T cells in transplantation and autoimmunity: recent progress and future directions, J Mol Cell Biol, vol.4, issue.1, pp.48-58, 2012. ,
Epigenetic plasticity of Cd8a locus during CD8 + T-cell development and effector differentiation and reprogramming, Nature Communications, 2014. ,
STAT6-mediated displacement of polycomb by trithorax complex establishes longterm maintenance of GATA3 expression in T helper type 2 cells, J Exp Med, vol.207, issue.11, pp.2493-2506, 2010. ,
cAMP responsive element modulator (CREM) ? mediates chromatin remodeling of CD8 during the generation of CD3+ CD4-CD8-T cells, J Biol Chem, vol.289, issue.4, pp.2361-2370, 2014. ,
Cd8 enhancer E8I and Runx factors regulate CD8? expression in activated CD8+ T cells, Proc Natl Acad Sci, 2011. ,
The proliferative in vivo activities of lpr double-negative T cells and the primary role of p59fyn in their activation and expansion, J Immunol, vol.159, issue.5, pp.2265-2273, 1997. ,
Double negative regulatory T cells in transplantation and autoimmunity: recent progress and future directions, J Mol Cell Biol, vol.4, issue.1, pp.48-58, 2012. ,
Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression, Nat Med, 2000. ,
Double negative regulatory T cells in transplantation and autoimmunity: recent progress and future directions, J Mol Cell Biol, vol.4, issue.1, pp.48-58, 2012. ,
Cutting edge: in vivo trogocytosis as a mechanism of double negative regulatory T cell-mediated antigen-specific suppression, J Immunol, vol.181, issue.4, pp.2271-2275, 2008. ,
Cutting edge: in vivo trogocytosis as a mechanism of double negative regulatory T cell-mediated antigen-specific suppression, J Immunol, vol.181, issue.4, pp.2271-2275, 2008. ,
Double-negative regulatory T cells: non-conventional regulators, Immunol Res, vol.35, issue.1-2, pp.163-178, 2006. ,
New differentiation pathway for double-negative regulatory T cells that regulates the magnitude of immune responses, Blood, vol.109, issue.9, pp.4071-4079, 2007. ,
, Adoptive transfer of double negative T regulatory cells induces B-cell death in vivo and alters rejection pattern of rat-to-mouse heart transplantation, Xenotransplantation, 2008.
The nature and mechanisms of DN regulatory T-cell mediated suppression, Human immunology, 2002. ,
Adoptive transfer of DNT cells induces long-term cardiac allograft survival and augments recipient CD4(+)Foxp3(+) Treg cell accumulation, Transpl Immunol, vol.24, issue.2, pp.119-126, 2011. ,
Regulation of antigen-expressing dendritic cells by double negative regulatory T cells, Eur J Immunol, vol.41, issue.9, pp.2699-2708, 2011. ,
Characterization of the immunoregulatory function of human TCR-??+ CD4-CD8-double-negative T cells, Eur J Immunol, vol.41, issue.3, pp.739-748, 2011. ,
Double-negative regulatory T cells induce allotolerance when expanded after allogeneic haematopoietic stem cell transplantation, Br J Haematol, vol.141, issue.2, pp.170-178, 2008. ,
New differentiation pathway for double-negative regulatory T cells that regulates the magnitude of immune responses, Blood, vol.109, issue.9, pp.4071-4079, 2007. ,
, Transplantation de cellules souches, 2018.
Genomic polymorphisms of the innate immune system and allogeneic stem cell transplantation, Expert Rev Hematol, 2010. ,
Double-negative regulatory T cells induce allotolerance when expanded after allogeneic haematopoietic stem cell transplantation, Br J Haematol, vol.141, issue.2, pp.170-178, 2008. ,
Characterization of CD3+CD4-CD8-(double negative) T cells reconstitution in patients following hematopoietic stem-cell transplantation, Transpl Immunol, vol.25, issue.4, pp.180-186, 2011. ,
Advances on Non-CD4 + Foxp3+ T Regulatory Cells: CD8+, Type 1, and Double Negative T Regulatory Cells in Organ Transplantation, Transplantation, vol.99, issue.8, pp.1553-1559, 2015. ,
The C-terminal region of hepatitis C core protein is required for Fas-ligand independent apoptosis in Jurkat cells by facilitating Fas oligomerization, Virology, vol.312, issue.2, pp.320-329, 2003. ,
A new flow cytometric assay for the simultaneous analysis of antigen-specific elimination of T cells in heterogeneous T cell populations, J Immunol Methods, vol.344, issue.2, pp.98-108, 2009. ,
CD4/CD8 Double-negative Mycosis Fungoides Mimicking Erythema Gyratum Repens in a Patient with Underlying Lung Cancer, Nagase K, Acta Derm Venereol, 2014. ,
CD45RA+ immunophenotype in mycosis fungoides: clinical, histological and immunophenotypical features in 22 patients, J Cutan Pathol, vol.28, issue.7, pp.356-362, 2001. ,
CD4/CD8 Double-negative Mycosis Fungoides: A Case Report and Literature Review, Yonago Acta Med, vol.62, issue.1, pp.153-158, 2019. ,
CD4/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: an immunohistochemical variant of mycosis fungoides, J Am Acad Dermatol, vol.55, issue.2, pp.276-284, 2006. ,
The prognosis of early mycosis fungoides is not influenced by phenotype and Tcell clonality, Br J Dermatol, vol.159, issue.4, pp.881-886, 2008. ,
Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin, Blood, vol.88, issue.11, pp.4265-4274, 1996. ,
Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease, J Pediatr Gastroenterol Nutr, vol.44, issue.2, pp.265-267, 2007. ,
Hepatosplenic alphabeta T-cell lymphoma: an unusual case with clinical, histologic, and cytogenetic features of gammadelta hepatosplenic T-cell lymphoma, Am J Surg Pathol, vol.24, issue.7, pp.1027-1032, 2000. ,
Hepatosplenic T-cell lymphoma, Indian J Hematol Blood Transfus, vol.27, issue.1, pp.39-42, 2011. ,
Multifaceted adult T-cell leukemia/lymphoma in India: a case series, Indian J Dermatol, vol.60, issue.1, p.103, 2015. ,
Adult T-cell leukaemia/lymphoma, J Clin Pathol, vol.60, issue.12, pp.1373-1377, 2007. ,
CD4 and CD8 double-negative adult T-cell leukemia/lymphoma with monomorphic cells expressing CD99: a diagnostic challenge in a country non-endemic for human T-cell leukemia virus, Pathol Int, vol.63, issue.2, pp.132-137, 2013. ,
Hepatosplenic T-cell lymphoma, Indian J Hematol Blood Transfus, vol.27, issue.1, pp.39-42, 2011. ,
Epidemiology of pancreatic cancer, World J Gastroenterol, vol.22, issue.44, pp.9694-9705, 2016. ,
Double-negative T Cells Inhibit Proliferation and Invasion of Human Pancreatic Cancer Cells in Co-culture, Anticancer Res, vol.39, issue.11, pp.5911-5918, 2019. ,
ALI multilayered co-cultures mimic biochemical mechanisms of the cancer cellfibroblast cross-talk involved in NSCLC MultiDrug Resistance, BMC Cancer, vol.19, issue.1, p.854, 2019. ,
Anti-leukemia effect of ex vivo expanded DNT cells from AML patients: a potential novel autologous T-cell adoptive immunotherapy, Leukemia, vol.25, issue.9, pp.1415-1422, 2011. ,
The PTEN/NRF2 axis promotes human carcinogenesis, Antioxid Redox Signal, vol.21, issue.18, pp.2498-2514, 2014. ,
CD3 + CD4 neg CD8 neg (double negative) T lymphocytes and NKT cells as the main cytotoxic-related-CD107a + cells in lesions of cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis. Parasit Vectors, vol.10, p.219, 2017. ,
, Maladies-auto-immunes
TCR ?? + CD3 + CD4 -CD8 -(double negative) T cells in autoimmunity, Autoimmun Rev, vol.17, issue.4, pp.422-430, 2018. ,
Systemic lupus erythematosus, N Engl J Med, vol.365, issue.22, pp.2110-2121, 2011. ,
Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys, J Immunol, vol.181, issue.12, pp.8761-8766, 2008. ,
Human double-negative T cells in systemic lupus erythematosus provide help for IgG and are restricted by CD1c, J Immunol, vol.165, issue.9, pp.5338-5344, 2000. ,
Mechanistic target of rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic lupus erythematosus, J Immunol, vol.191, issue.5, pp.2236-2246, 2013. ,
CaMK4-dependent activation of AKT/mTOR and CREM-? underlies autoimmunityassociated Th17 imbalance, J Clin Invest, vol.124, issue.5, pp.2234-2245, 2014. ,
Increased Interleukin-17F is Associated with Elevated Autoantibody Levels and More Clinically Relevant Than Interleukin-17A in Primary Sjögren's Syndrome, J Immunol Res, vol.2017, p.4768408, 2017. ,
IL-17-producing CD4-CD8-T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjogren's syndrome, Ann Rheum Dis, vol.72, issue.2, pp.286-292, 2013. ,
Cracking the BAFF code, Nat Rev Immunol, vol.9, issue.7, p.491, 2009. ,
Excessive production of IFN-gamma in patients with systemic lupus erythematosus and its contribution to induction of B lymphocyte stimulator/B cell-activating factor/TNF ligand superfamily-13B, J Immunol, vol.181, issue.3, pp.2211-2219, 2008. ,
Human TCR-alpha beta+ CD4-CD8-T cells can derive from CD8+ T cells and display an inflammatory effector phenotype, J Immunol, vol.183, issue.7, pp.4675-4681, 2009. ,
TCR + CD3 + CD4 -CD8 -effector T cells in psoriasis, Clin Immunol, vol.181, pp.51-59, 2017. ,
Psoriasis as a systemic disease, Clin Dermatol, vol.32, issue.3, pp.343-350, 2014. ,
Immunology of psoriasis, Annu Rev Immunol, vol.32, pp.227-255, 2014. ,
Potential role of IL-17-producing CD4/CD8 double negative ?? T cells in psoriatic skin inflammation in a TPA-induced STAT3C transgenic mouse model, PD-1/PD-L and autoimmunity:a growing relationship. Zamani MR, vol.85, pp.27-35, 2016. ,
Le syndrome lymphoprolifératif avec auto-immunité: un défaut hérité ou acquis d'apoptose lymphocytaire ,
, Med Sci (Paris), vol.22, issue.6-7, pp.645-650, 2006.
Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis, Blood, vol.89, issue.4, pp.1341-1348, 1997. ,
The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis, Blood, vol.98, issue.1, pp.194-200, 2001. ,
The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis, Blood, vol.98, issue.1, pp.194-200, 2001. ,
Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop, Blood, vol.116, issue.14, pp.35-40, 2010. ,
Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance, Am J Hum Genet, vol.64, issue.4, pp.1002-1014, 1999. ,
, Normalfunction gène FAS génetic home ref
CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosisinducing ligand mediate ischemia-induced apoptosis in neurons, J Neurosci, vol.19, issue.10, pp.3809-3817, 1999. ,
Isolation and characterization of human antigen-specific TCR alpha beta+ CD4(-)CD8-double-negative regulatory T cells, Blood, vol.105, issue.7, pp.2828-2835, 2005. ,
Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations, Science, vol.288, issue.5475, pp.2354-2357, 2000. ,
FAS haploinsufficiency is a common disease mechanism in the human autoimmune lymphoproliferative syndrome, J Immunol, vol.186, issue.10, pp.6035-6043, 2011. ,
Autoimmune lymphoproliferative syndrome (ALPS) in a child from consanguineous parents: a dominant or recessive disease, Pediatr Res, vol.47, issue.3, pp.336-343, 2000. ,
CTLA-4 haploinsufficiency in a patient with an autoimmune lymphoproliferative disorder, J Allergy Clin Immunol, vol.140, issue.3, pp.862-864, 2017. ,
Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib, BMC Med Genet, vol.8, p.41, 2007. ,
Atlas of Genetics and Cytogenetics in Oncology and Haematology, 2014. ,
Autoimmune Lymphoproliferative Syndrome: An Overview, Arch Pathol Lab Med, vol.144, issue.2, pp.245-251, 2020. ,
Programmed Cell Death Initiation and Execution in Budding Yeast, Genetics, vol.200, issue.4, pp.1003-1014, 2015. ,
Development of lymphoma in Autoimmune Lymphoproliferative Syndrome (ALPS) and its relationship to Fas gene mutations, Leuk Lymphoma, vol.45, issue.3, pp.423-431, 2004. ,
Régulation de l'apoptose des lymphocytes T par les protéines de la famille TSC22D. Sciences agricoles, 2011. ,
Autoimmune lymphoproliferative syndrome: more than a FAScinating disease, vol.6, 1000. ,
Le syndrome lymphoprolifératif avec auto-immunité : un défaut hérité ou acquis d'apoptose lymphocytaire ,
, Med Sci (Paris), vol.22, issue.6-7, pp.645-650, 2006.
Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop, Blood, vol.116, issue.14, pp.35-40, 2010. ,
Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome, J Allergy Clin Immunol, vol.125, issue.4, pp.946-949, 2010. ,
Identifying autoimmune lymphoproliferative syndrome in children with Evans syndrome: a multi-institutional study, Blood, vol.115, issue.11, pp.2142-2145, 2010. ,
Increased lymphocyte Fas expression and high incidence of common variable immunodeficiency disorder in childhood Evans' syndrome, Clin Immunol, vol.125, issue.3, pp.224-229, 2007. ,
Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop, Blood, vol.116, issue.14, pp.35-40, 2010. ,
FAS-L, IL-10, and double-negative CD4-CD8-TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function, Blood, vol.113, issue.13, pp.3027-3030, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00397943
X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis, Clin Immunol, vol.149, issue.1, pp.133-141, 2013. ,
FAS haploinsufficiency is a common disease mechanism in the human autoimmune lymphoproliferative syndrome, J Immunol, vol.186, issue.10, pp.6035-6043, 2011. ,
Development of lymphoma in Autoimmune Lymphoproliferative Syndrome (ALPS) and its relationship to Fas gene mutations, Leukemia & lymphoma, 2004. ,
, HHV8/KSHV-Positive Lymphoproliferative Disorders and the Spectrum of Plasmablastic and Plasma Cell Neoplasms: 2015 SH/EAHP Workshop Report-Part, vol.3, pp.171-187, 2017.
HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy, Blood, vol.123, pp.2924-2933, 2014. ,
Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease, PLoS One, vol.14, issue.6, p.218660, 2019. ,
iNKT and memory B-cell alterations in HHV-8 multicentric Castleman disease, Blood, vol.129, issue.7, pp.855-865, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01515291
Recurrent PDGFRB mutations in unicentric Castleman disease, Leukemia, vol.33, issue.4, pp.1035-1038, 2019. ,
Autoimmune Lymphoproliferative Syndrome: An Overview, Arch Pathol Lab Med, vol.144, issue.2, pp.245-251, 2020. ,
IL-17 protects T cells from apoptosis and contributes to development of ALPSlike phenotypes, Blood, vol.123, issue.8, pp.1178-1186, 2014. ,
Defective anti-polysaccharide response and splenic marginal zone disorganization in ALPS patients, Blood, vol.124, issue.10, pp.1597-1609, 2014. ,
NRAS mutation causes a human autoimmune lymphoproliferative syndrome, Proc Natl Acad Sci, vol.104, issue.21, pp.8953-8958, 2007. ,
Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency, Nature, vol.419, issue.6905, pp.395-399, 2002. ,
JB Oliveira Autoimmune lymphoproliferative syndrome.. Primary Immunodeficiency Diseases books, 2013. ,
Progression of Lung Cancer Is Associated with Increased Dysfunction of T Cells Defined by Coexpression of Multiple Inhibitory Receptors, Cancer Immunol Res, vol.3, issue.12, pp.1344-1355, 2015. ,
Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects, J Clin Immunol, vol.23, issue.5, pp.385-400, 2003. ,
Clinical features and genetic analysis of Taiwanese patients with the hyper IgM syndrome phenotype, Pediatr Infect Dis J, vol.32, issue.9, pp.1010-1016, 2013. ,
The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study, BMC Med, vol.6, p.32, 2008. ,
Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gainof-function mutations, Blood, vol.125, issue.4, pp.591-599, 2015. ,
How I treat autoimmune lymphoproliferative syndrome, Blood, vol.118, issue.22, pp.5741-5751, 2011. ,
Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial, Blood, vol.127, issue.1, pp.17-28, 2016. ,
Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome, Blood, vol.115, issue.25, pp.5164-5169, 2010. ,
What's up in the ALPS, Curr Opin Immunol, vol.49, pp.79-86, 2017. ,
Principe de la cytométrie en flux et du tri cellulaire, Unité de Biologie fonctionnelle et adaptative -CNRS UMR 8251, 2020. ,